Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03896737
Title Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Myeloma Network
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | GRC | CZE

Facility Status City State Zip Country Details
University Hospital Ostrava Ostrava 708 52 Czechia Details
General Hospital of Athens "Alexandra" Athens 115 28 Greece Details
A.O.U. Maggiore della Carità di Novara Novara 28100 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field